His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.
A Big Pharma giant quietly bought one AI-designed drug for $4 billion designed by a tiny AI-biotech company. Wall Street doesn't yet grasp how this company is quietly revolutionizing the drug discovery business but this won't stay quiet much longer.
The Ukraine war isn't being won just by its soldiers, it's being won by software. This "living software" has been such a difference-maker, the U.S. Army just signed a $1 billion contract with the company.
Do you want to see who I believe will be the next president of the U.S.A? It won't be Biden... And it won't be Trump.
Ukraine has a new weapon that's never been used before in war. This "living software" has been its secret weapon against Russia. The Wall Street Journal Reports: "it's a technical revolution." Early investors can reap 5,633% gains on the small company that makes it.
His award-winning system pinpointed NVDA and META before both stocks doubled. Now it's flashing "BUY" on this under-the-radar A.I. stock.